Anti-tuberculosis therapy
Showing 1 - 25 of >10,000
Tuberculosis Infection Trial in Zurich (Nivaquine ® (Chloroquine))
Recruiting
- Tuberculosis Infection
- Nivaquine ® (Chloroquine)
-
Zurich, SwitzerlandClinical Trial Center
Jun 28, 2022
Tuberculosis, Pulmonary Trial in Houston (Azacitidine Injection)
Not yet recruiting
- Tuberculosis, Pulmonary
- Azacitidine Injection
-
Houston, TexasHarris Health System - Ben Taub Hospital
Sep 1, 2022
Tuberculous Uveitis Trial in Jakarta Pusat (Anti Tuberculosis Drug, Prednisone tablet)
Enrolling by invitation
- Tuberculous Uveitis
- Anti Tuberculosis Drug
- Prednisone tablet
-
Jakarta Pusat, DKI Jakarta, IndonesiaCipto Mangunkusumo National Central General Hospital
Sep 12, 2021
Tuberculous Lymphadenitis Trial in Taipei (Prednisolone, standard anti-tuberculosis agents)
Recruiting
- Tuberculous Lymphadenitis
- Prednisolone
- standard anti-tuberculosis agents
-
Taipei, TaiwanNational Taiwan University Hospital
May 17, 2023
Tuberculosis, HIV I Infection, Sepsis Trial in Sanya Juu, Mbarara (Immediate anti-TB therapy, Sepsis-specific dose anti-TB
Recruiting
- Tuberculosis
- +2 more
- Immediate anti-TB therapy
- Sepsis-specific dose anti-TB therapy
-
Sanya Juu, Tanzania
- +1 more
Dec 10, 2021
HIV, Tuberculosis Trial in Worldwide (Levonorgestrel (LNG))
Completed
- HIV Infections
- Tuberculosis
- Levonorgestrel (LNG)
-
Chicago, Illinois
- +17 more
Dec 22, 2021
CD4/CD8+ Interferon Gamma Release Assay for Monitoring
Active, not recruiting
- Tuberculosis
- Interferon gamma release assay (IGRA)
-
Milano, ItalyIRCCS San Raffaele Scientific Institute
Feb 13, 2023
HIV, Tuberculosis Trial in Bangkok (LPV/r)
Completed
- HIV Infections
- Tuberculosis
-
Bangkok, ThailandHIV-NAT Thai Red Cross AIDS Research Center
Jul 15, 2020
Tuberculosis Trial in Kuala Terengganu (VIDEO OBSERVED THERAPY)
Not yet recruiting
- Tuberculosis
- VIDEO OBSERVED THERAPY
-
Kuala Terengganu, Terengganu, MalaysiaHospital Sultanah Nur Zahira
Aug 15, 2023
HIV, Tuberculosis Trial in Worldwide (Efavirenz (EFV), Rifampin-containing anti-TB therapy)
Completed
- HIV Infections
- Tuberculosis
- Efavirenz (EFV)
- Rifampin-containing anti-TB therapy
-
Pune, Maharashtra, India
- +6 more
Oct 28, 2021
Tuberculosis, Drug Induced Liver Injury, Hepatitis Trial in Bangkok (N acetyl cysteine)
Recruiting
- Tuberculosis
- +2 more
- N acetyl cysteine
-
Bangkok, ThailandFaculty of Medicine, Siriraj Hospital
Feb 12, 2023
HIV, AIDS Trial in Phnom Penh (Community-based ART delivery (CAD), ART multi-month dispensing (MMD))
Recruiting
- HIV Infections
- AIDS
- Community-based ART delivery (CAD)
- ART multi-month dispensing (MMD)
-
Phnom Penh, Cambodia
- +2 more
Aug 31, 2021
Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet
Recruiting
- Tuberculosis
- +2 more
- Observational PK study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Dec 21, 2022
Tuberculosis Trial in Singapore (Doxycycline, Placebo)
Not yet recruiting
- Tuberculosis
- Doxycycline
- Placebo
-
Singapore, SingaporeNational University Hospital
Jul 21, 2022
Tuberculosis, Multidrug Resistant Tuberculosis Trial in Paris (Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard
Not yet recruiting
- Tuberculosis
- Multidrug Resistant Tuberculosis
- Tedizolid arm (SIVEXTRO®)
- +2 more
-
Paris, FranceBacteriology department- Hôpital Saint-Antoine
Sep 6, 2022
Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)
Not yet recruiting
- Tuberculosis, Pulmonary
- HIV
- Bedaquiline
- +6 more
-
Port-au-Prince, Haiti
- +1 more
Nov 11, 2022
Kidney Transplant Infection, Tuberculosis, Isoniazid Toxicity Trial (Isoniazid, without any additional anti-tuberculosis
Not yet recruiting
- Kidney Transplant Infection
- +2 more
- Isoniazid
- without any additional anti-tuberculosis treatment
- (no location specified)
Mar 21, 2022
MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)
Active, not recruiting
- MDR-TB
- Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
- +9 more
-
Addis Ababa, Ethiopia
- +12 more
Oct 12, 2022
HIV, Tuberculosis Trial in Bangkok (indinavir/ritonavir)
Completed
- HIV Infections
- Tuberculosis
-
Bangkok, ThailandHIV-NAT Thai Red Cross AIDS Research Center
Jul 15, 2020
Tuberculosis Trial in Kota Kinabalu (Mobile Application, Direct Observed Therapy)
Not yet recruiting
- Tuberculosis
- Mobile Application
- Direct Observed Therapy
-
Kota Kinabalu, Sabah, MalaysiaMohd Fazeli bin Sazali
May 20, 2022
Multi-drug Resistant Tuberculosis Trial in China (18-month regimen containing 6 anti-TB drugs)
Completed
- Multi-drug Resistant Tuberculosis
- 18-month regimen containing 6 anti-TB drugs
-
Beijing, China
- +19 more
Oct 10, 2022
Tuberculosis Trial in Johannesburg (Pravastatin)
Completed
- Tuberculosis
-
Johannesburg, South AfricaChris Hani Baragwanath Hospital
Sep 26, 2022
Contributing Factors for Poor HIV Treatment Response in TB/HIV
Recruiting
- Tuberculosis
- +2 more
- Observational study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Mar 23, 2022
Tuberculosis Trial in Phnom Penh (ACF with a seed-and-recruit model, ACF targeting household and neighborhood contacts, ACF
Completed
- Tuberculosis
- ACF with a seed-and-recruit model
- +3 more
-
Phnom Penh, Cambodia
- +2 more
Nov 26, 2022